Vicore Pharma Holding AB Financial Ratios — VCRE Stock

Profitability (SEK)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	251.92	-69.97	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	24.81	-6.15	-10.49	-47.62	-11.86	-28.97	-39.29	-69.14	-73.09	-74.4	-19.92	-39.56
Return on Capital (%)	- -	223.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	-10.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	184.61	197.14	243.31	383.8	100	- -	- -	- -	- -	- -	100	100
EBITDA Margin (%)	- -	-583.31	-540.83	-780.4	-3,022.85	-8,186.22	- -	- -	- -	- -	- -	-174.09	-11,905.82
Operating Margin (%)	- -	-583.31	-540.83	-780.4	-3,022.85	-8,186.22	- -	- -	- -	- -	- -	-174.09	-11,905.82
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	10,302.56	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	1,608.34	-544.05	-780.75	-2,599.89	-4,267.91	- -	- -	- -	- -	- -	-154.45	-12,509.14
Profit Margin (%)	- -	1,608.34	-544.05	-780.75	-2,599.89	-4,267.91	- -	- -	- -	- -	- -	-154.22	-12,509.14
Net Income to Common Margin (%)	- -	1,608.34	-544.05	-780.75	-2,599.89	-4,267.91	- -	- -	- -	- -	- -	-154.22	-12,509.14
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	251.92	-69.97	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (SEK)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	- -	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	-0.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBITDA	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
Total Debt/EBIT	- -	-0.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt/EBIT	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EBITDA to Interest Expense	-9.01	-47.28	-168.26	-2,216.33	-454.4	-118.14	-3,478.63	-24,911.83	-26,674.55	-35,936.75	-160,444.5	-23,795	-7,574.08
EBITDA-CapEx/Interest Expense	-9.01	-137.66	-204.3	-2,576.33	-454.94	-123.82	-3,484.07	-25,411.83	-26,674.55	-36,311.75	-160,444.5	-23,795	-7,574.08
EBIT to Interest Expense	-9.01	-47.28	-168.26	-2,216.33	-454.4	-118.14	-3,478.63	-24,911.83	-26,674.55	-35,936.75	-160,444.5	-23,795	-7,574.08
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	6.72	12.53	6.3	-119.69	-105.29	-38.76	-60.33	-85.49	-141.49	-272.69	-244.74	-110.84	-146.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	2.79	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	16.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	2.53	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt to Equity	-35.05	-0.39	-30.73	-13.51	-41.72	-78.72	-58.33	-70.13	-76.75	-88.83	-73.26	-102.36	-52.78
Net Debt/Capital (%)	132.35	-2.91	128.77	8.65	26.24	65.78	47.68	41.7	31.55	21.79	21.5	46.59	24.52
EBITDA	-2	-5	-5	-7	-28	-42	-94	-149	-293	-287	-321	-190	-454
EBITDA-CapEx	-2	-14	-6	-8	-28	-44	-94	-152	-293	-290	-321	-190	-454
Operating Income (Loss)	-2	-5	-5	-7	-28	-42	-94	-149	-293	-287	-321	-190	-454

Liquidity (SEK)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.41	0.46	4.73	1.05	5.24	16.16	15.61	6.63	5.65	5.64	11.78	17.6	9.85
Current Ratio	7.8	0.57	4.96	1.18	5.4	16.31	15.72	6.82	5.75	5.81	12.1	18.2	10.28
Quick Ratio	7.41	0.46	4.73	1.05	5.24	16.16	15.61	6.63	5.65	5.64	11.78	17.6	9.85
CFO/Avg Current Liab	- -	-1.01	-0.82	-1.54	-6.45	-3.57	-5.64	-3.69	-4.66	-5.35	-5.71	-3.09	-4.08
Common Equity/Total Assets	6.72	12.53	6.3	-119.69	-105.29	-38.76	-60.33	-85.49	-141.49	-272.69	-244.74	-110.84	-146.08
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	2.79	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Capital (%)	- -	16.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	- -	2.53	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
CFO/Total Liabilities	- -	-49.81	-50.47	-119.79	-425.45	-204.38	-445.9	-230.64	-390.81	-613.03	-587.96	-248.99	-305.04
CFO/CapEx	- -	-0.3	-3.78	-6.71	-845.61	-16.52	-591.83	-39.98	- -	-99.97	- -	- -	- -
Altman's Z-Score	0.38	-0.53	0.22	-4.38	-3.65	-0.32	-1.22	-2.04	-4.01	-7.52	-4.64	-0.99	-2.35

Working Capital (SEK)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	3.77	7.06	6.36	5.68	4.84	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	96.93	51.71	57.41	64.23	75.44	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	-1.15	-0.57	-0.54	-1.07	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	-317.35	-642.78	-672.01	-342.51	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	414.28	694.48	729.41	406.73	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	96.93	51.71	57.41	64.23	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (SEK)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	14	2	25	4	24	225	188	249	294	257	334	1,156	578
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-14	- -	-25	-4	-24	-225	-265	-319	-371	-262	-483	-1,156	-1,167
Total Capital	3	9	6	-45	-68	-117	-206	-348	-638	-922	-1,218	-1,325	-1,780
Total Debt/Capital (%)	- -	16.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt / EV	- -	-7.14	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-14	- -	-25	-4	-24	-225	-188	-249	-294	-257	-334	-1,156	-578
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	1	1	1	1	1	- -	- -	- -	- -	- -	109	4
TTM EBITDA	-2	-5	-5	-7	-28	-42	-94	-149	-293	-287	-321	-190	-454
TTM Operating Income	-2	-5	-5	-7	-28	-42	-94	-149	-293	-287	-321	-190	-454
TTM Cash Flow to Firm	- -	-3	-4	-7	-28	-33	-87	-120	-265	-300	-250	-165	-376
TTM Free Cash Flow to Firm	- -	7	-3	-6	-28	-31	-87	-117	-265	-297	-250	-165	-376

Multiples (SEK)

API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-14	- -	-25	-4	-24	-225	-265	-319	-371	-262	-483	-1,156	-1,167
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EV/EBITDA High	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EV/EBITDA Low	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EV/EBIT Average	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EV/EBIT High	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
EV/EBIT Low	7.1	0.04	5.54	0.64	0.85	5.4	2	1.66	1	0.89	1.04	6.07	1.27
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Average	-14	- -	-25	-4	-24	-225	-188	-249	-294	-257	-334	-1,156	-578
Enterprise Value High	-14	- -	-25	-4	-24	-225	-188	-249	-294	-257	-334	-1,156	-578
Enterprise Value Low	-14	- -	-25	-4	-24	-225	-188	-249	-294	-257	-334	-1,156	-578

Shares Outstanding	13	13	14	14	19	34	52	62	74	84	115	235	282
Diluted Weighted Avg Shares	13	17	14	14	17	24	44	56	72	74	97	137	240
Basic Weighted Avg Shares	13	10	14	14	17	24	44	56	72	74	97	137	240
Revenue per Share	- -	0.09	0.06	0.06	0.05	0.02	- -	- -	- -	- -	- -	0.8	0.02
EBITDA per Share	-0.15	-0.52	-0.31	-0.46	-1.61	-1.77	-2.12	-2.68	-4.1	-3.87	-3.32	-1.39	-1.89
Operating Income per Share	-0.15	-0.52	-0.31	-0.46	-1.61	-1.77	-2.12	-2.68	-4.1	-3.87	-3.32	-1.39	-1.89
Basic EPS, GAAP	-0.12	1.44	-0.32	-0.46	-1.39	-0.92	-2.1	-2.63	-4.14	-3.89	-3.22	-1.23	-1.99
Basic EPS from Cont Ops	-0.12	1.44	-0.32	-0.46	-1.39	-0.92	-2.1	-2.63	-4.14	-3.89	-3.22	-1.23	-1.99
Diluted EPS, GAAP	-0.12	0.8	-0.32	-0.46	-1.39	-0.92	-2.1	-2.63	-4.14	-3.89	-3.22	-1.23	-1.99
Diluted EPS from Cont Ops	-0.12	0.8	-0.32	-0.46	-1.39	-0.92	-2.1	-2.63	-4.14	-3.89	-3.22	-1.23	-1.99
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.3	-0.25	-0.5	-1.6	-1.4	-1.97	-2.15	-3.7	-4.04	-2.58	-1.21	-1.57
Free Cash Flow per Basic Share	- -	-1.3	-0.32	-0.58	-1.6	-1.49	-1.97	-2.2	-3.7	-4.08	-2.58	-1.21	-1.57
Cash & Equivalents per Share	1.05	0.18	1.74	0.3	1.38	9.55	5.98	5.71	5.18	3.53	5	8.45	4.86
Book Value per Share	0.26	0.78	0.39	-3.12	-3.87	-4.97	-4.65	-6.23	-8.91	-12.42	-12.62	-9.68	-7.42
Tangible Book Value per Share	0.93	1.75	2.71	1.04	2.34	9.19	5.73	5.09	4.41	2.98	4.69	8.25	4.57

Vicore Pharma Holding AB

Profitability (SEK)

Credit (SEK)

Liquidity (SEK)

Working Capital (SEK)

Enterprise Value (SEK)

Multiples (SEK)

Per Share Data Items (SEK)